- Home
- AMLX vs SLVM Comparison
AMLX vs SLVM Comparison
Compare AMLX & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | SLVM |
|---|---|---|
| Founded | 2014 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMLX | SLVM |
|---|---|---|
| Price | $13.37 | $38.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $21.56 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 979.0K | 328.1K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $380,786,000.00 | ★ $3,351,000,000.00 |
| Revenue This Year | N/A | $0.93 |
| Revenue Next Year | N/A | $1.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $4.76 | $35.53 |
| 52 Week High | $18.61 | $56.80 |
Technical Indicators
Market Signals| Indicator | AMLX | SLVM |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 43.02 |
| Support Level | $12.19 | $37.09 |
| Resistance Level | $15.37 | $44.05 |
| Average True Range (ATR) | 0.65 | 1.25 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 40.53 | 62.37 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.